Post-inflammatory pulmonary fibrosis in a discharged COVID-19 patient: Effectively treated with Pirfenidone
<p>The coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) has led to a pandemic situation. According to the WHO classification, COVID-19 patients could be classified with severity as uncomplicated illness, mild pneumonia, severe pneumonia,...
Saved in:
Main Authors: | Zhan Xi (Author), Zhao Zhigang (Author), Li Ting (Author) |
---|---|
Format: | Book |
Published: |
Archives of Pulmonology and Respiratory Care - Peertechz Publications,
2020-06-23.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary Fibrosis
Published: (2019) -
Idiopathic Pulmonary Fibrosis
Published: (2022) -
State of the Art in Idiopathic Pulmonary Fibrosis
Published: (2023) -
A Post-Mortem Examination of COVID-19 Pulmonary Pathology in 9 Cases
by: Alexis Bloom, et al.
Published: (2020) -
Hyperuricemia in Renal patients: Treat or not to treat
by: Muhammad Tanzeel Abbasi Muhammad Rashid Asghar, et al.
Published: (2021)